Tempus AI, Inc. (TEM) FY2026 Q2 P&L / Income Statement

Tempus AI, Inc. (TEM) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and Service by Health Care Organization, Revenue Sources. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total net revenue

382,486,000 US dollars

Cost of revenue (calculated)

135,988,000 US dollars

Gross profit (calculated)

246,498,000 US dollars

Operating expenses (calculated)

322,411,000 US dollars

Loss from operations

negative 75,913,000 US dollars

Other income (expense), net (calculated)

84,728,000 US dollars

Income (loss) before (provision for) benefit from income taxes

8,815,000 US dollars

(Provision for) benefit from income taxes

309,000 US dollars

Net income (loss)

5,642,000 US dollars

Insights Product

77,700,000 US dollars

Next Product

6,300,000 US dollars

Trials Product

9,000,000 US dollars

Clinical Order - Third-Party Payor

264,400,000 US dollars

Genomics Product - Self-Pay

24,900,000 US dollars

Undisclosed (calculated)

186,000 US dollars

Cost of revenues

135,988,000 US dollars

Selling, general and administrative

225,845,000 US dollars

Research and development

52,637,000 US dollars

Technology research and development

43,929,000 US dollars

Losses from equity method investments

negative 2,864,000 US dollars. Reported below-tax contribution to net income.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.